Ju Fu Tang Biotech Holdings Co., Ltd (HKG:8217)

HKG:8217 Revenue

In the fiscal year ending March 31, 2026, Ju Fu Tang Biotech Holdings had annual revenue of 37.56M HKD with 3.74% growth. Ju Fu Tang Biotech Holdings had revenue of 20.24M in the half year ending March 31, 2026, with 38.57% growth. That makes Ju Fu Tang Biotech Holdings the 40,111th largest company in the world by revenue and 2,453rd in Hong Kong.

• Revenue: 37.56M
• Revenue Growth: +3.74%
• P/S Ratio: 0.72
• Revenue / Employee: 1.63M
• Employees: 23
• Market Cap: 26.87M

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Provision of Civil Engineering, Decoration and Renovation Works 35.44M 94.4%
• Health Technology Business 2.11M 5.6%

By Geography

Chart

• Hong Kong 35.44M 94.4%
• People's Republic of China (the PRC) 2.11M 5.6%

Fiscal year ended Mar 31, 2026 See the full HKG:8217 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	37.56M	1.35M	3.74%
Mar 31, 2025	36.20M	1.06M	3.02%
Mar 31, 2024	35.14M	-69.46M	-66.40%
Mar 31, 2023	104.60M	11.85M	12.77%
Mar 31, 2022	92.75M	-75.55M	-44.89%

Data Source: S&P Global Market Intelligence Last updated: Jul 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 27, 2026

Data Sources Report a data error